CORONAVIRUS-RELATED ANXIETY WITH HYPERGLYCEMIA IN TYPE 2 DIABETES PATIENTS

• Main Authors: Kholisotul Hikmah (Author), Helda (Author), Caroline Killeen (Author)
• Format: Book
• Published: Universitas Airlangga, 2022-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary

Background: COVID-19 might also predispose individuals to elevate blood glucose as the effect of anxiety. Blood glucose level is an important risk factor for the prognosis of disease among diabetes patients. Purpose: This study aimed to assess the effect of Coronavirus-related anxiety with hyperglycemia incidence among type 2 diabetes patients. Methods: A cross-sectional study was conducted among 143 individuals with type 2 diabetes mellitus, from 25 January to 29 February 2021. This study was conducted both online and by assessing archives of medical records using random samples. Results: A total of 143 respondents completed the questionnaire, with 59.44% females and 40.56% males. More than half of the respondents (55.94%) who reported hyperglycemia showed COVID-19 anxiety, and 51.05% of them experienced ≥ 8 years of diabetes. COVID-19 anxiety was associated positively with the risk of hyperglycemia among type 2 diabetes patients (PR>1). Severe worry about the pandemic had the highest risk of hyperglycemia compared to moderate and mild anxiety. This finding is confounded by diabetes duration (PR discrepancy >10% and PR>1 for ≥8 years long-duration). Conclusion: This study suggests a positive association between COVID-19 anxiety and hyperglycemia while the degree of anxiety is associated with an increased risk of hyperglycemia.

Item Description

10.20473/jbe.V10I22022.111-120
2301-7171
2541-092X